Decline in forced vital capacity in subjects with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial compared with healthy reference subjects

By sjmartinez • July 5, 2022

Maher TM, Bourdin A, Volkmann ER, Vettori S, Distler JHW, Alves M, Stock C, Distler O. Decline in forced vital capacity in subjects with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial compared with healthy reference subjects. Respir Res. 2022 Jul 5;23(1):178. doi: 10.1186/s12931-022-02095-6. PMID: 35790961; PMCID: PMC9258095.

Tags: Connective tissue diseases, Publications, Pulmonary fibrosis, Rheumatology, systemic Scleroderma, Vital capacity

Effects of macitentan and selexipag across prognostic age groups in patients with pulmonary arterial hypertension

Channick R, Medrek S, Delcroix M, Gaine S, Jansa P, Lang I, McLaughlin V, Mehta S, Pulido T, Sastry B, Souza R, Torbicki A, Zhao[...]

T cell immune senescence is associated with frailty and sarcopenia in lung transplant candidates

Schaenman JM, Pickering H, Reed EF, Rossetti M, Seligman B, Weigt SS, Shino M, Sayah D, Belperio J, Hu A, Prosper A, Ruchalski K, Ardehali[...]

“It Looks Arterial”: The Chest X-Ray of Nightmares

Chen T. "It Looks Arterial": The Chest X-Ray of Nightmares. Cureus. 2025 Feb 23;17(2):e79532. doi: 10.7759/cureus.79532. PMID: 40144411; PMCID: PMC11937719.